Improving the solubility of pseudo-hydrophobic Alzheimer's Disease medicinal chemicals through co-crystal formulation

Natural products are ligands and potential inhibitors of Alzheimer's disease (AD) tau. Dihydromyricetin (DHM) is a CNS active natural product. Despite having signature polyphenolic character, DHM is ostensibly hydrophobic owing to intermolecular hydrogen bonds that shield hydrophilic phenols. Our research shows DHM becomes ionized at near-neutral pH allowing formulation of salts with transformed solubility. The MicroED co-crystal structure with trolamine reveals DHM salts as metastable solids with unlocked hydrogen bonding and a thermodynamic bent to solubilize in water. All salt formulations show better inhibitory activity against AD tau than the non-salt form, with efficacies correlating to enhanced solubilities. These results underscore the role of structural chemistry in guiding selection of solubilizing agents for chemical formulation. We propose DHM salts are appropriate formulations for research as dietary supplements to promote healthy aging by combating protein misfolding. Additionally, DHM is a suitable lead for medicinal chemistry and possible development of CNS pharmaceuticals.

Structure-based inhibitors of tau aggregation

Aggregated tau protein is associated with over 20 neurological disorders, which include Alzheimer's disease. Previous work has shown that tau's sequence segments VQIINK and VQIVYK drive its aggregation, but inhibitors based on the structure of the VQIVYK segment only partially inhibit full-length tau aggregation and are ineffective at inhibiting seeding by full-length fibrils. Here we show that the VQIINK segment is the more powerful driver of tau aggregation. Two structures of this segment determined by the cryo-electron microscopy method micro-electron diffraction explain its dominant influence on tau aggregation. Of practical significance, the structures lead to the design of inhibitors that not only inhibit tau aggregation but also inhibit the ability of exogenous full-length tau fibrils to seed intracellular tau in HEK293 biosensor cells into amyloid. We also raise the possibility that the two VQIINK structures represent amyloid polymorphs of tau that may account for a subset of prion-like strains of tau.

Versuche zur Oxidation von 1.5-Benzothiazepin — bzw. 1.5-Benzoxazepin- 2.4-3H.5H-dionen / Investigations Concerning Oxidation Reactions of 1,5-Benzthiazepin — and 1,5-Benzoxazepin- 2,4-3H,5H -diones

Attempts to oxidize the 1,5-benzothiazepin-2,4-3H,5H-dione (1) using NaNO2/Acetic acid lead to isolation of two ring contracted products, namely the 1,4-benzthiazin-derivatives 4 and 5. A reasonable reaction pathway concerning the formation of these compounds is discussed. A simple synthesis of 6-methyI-1,5-benzoxazepin-2,4-3H,5H-dione (13) is described, the transformation of which into the corresponding vic. trione fails, even using a great number of oxidizing procedures. In some cases so far unknown malonic acid derivatives 14, 15 and 16 can be obtained.